Skip to main content

palupiprant

Generic: Palupiprant

palupiprant: 2 clinical trials tracked.

palupiprant evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about palupiprant, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (2)

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

NCT05358691Registry updated 2025-04-16·Phase 1
Withdrawn

Primary endpoint: Eastern Cooperative Oncology Group Performance Status (ECOGPS) to measure how participants disease is progressing

Interventionalopen0 targetStarted 2024-11Completion 2028-061 site · United StatesRutgers, The State University of New Jersey

An Open-Label, Multicenter, Phase 1a Study of AN2025 and AN0025 in Double Combination With Atezolizumab and in Triple Combination With Atezolizumab in Patients With Advanced Solid Tumors

NCT04975958Registry updated 2025-06-22·Phase 1
Completed

Primary endpoint: Primary Outcome Measure - Dose Limiting Toxicities (DLTs)

Interventionalopen47 enrolledStarted 2021-09Completion 2025-015 sites · United StatesAdlai Nortye Biopharma Co., Ltd.